September 22, 2014 5:04 AM ET

Biotechnology

Company Overview of TorreyPines Therapeutics, Inc.

Company Overview

As of September 29, 2009, TorreyPines Therapeutics, Inc. was acquired by Raptor Pharmaceuticals Corp., in a reverse merger transaction. TorreyPines Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of small molecule compounds in the United States. The company’s products under development include Tezampanel, which has completed Phase II clinical trial for the treatment of migraine; NGX426, an oral prodrug of tezampanel, which has completed Phase I clinical trial for the treatment of migraine and neuropathic pain; and NGX267, a Phase II clinical trial product for the treatment of xerostomia. It also develops a Gamma-secretase modulator drug discovery pro...

11085 North Torrey Pines Road

Suite 300

La Jolla, CA 92037

United States

10 Employees

Phone:

858-623-5665

Fax:

858-623-5666

Key Executives for TorreyPines Therapeutics, Inc.

TorreyPines Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Ocean Genetics Inc. United States
OmniVec LLC United States
Ophthalmic Solutions Inc United States
Neumedicines, Inc. United States
Evolutionary Genomics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TorreyPines Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.